These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1202 related items for PubMed ID: 24360985

  • 1. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á, Aguiló R, Curull V, Suárez-Piñera M, Rodríguez-Fuster A, Rodríguez de Dios N, Pijuan L, Zuccarino F, Vollmer I, Sánchez-Font A, Belda-Sanchis J, Arriola E.
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [Abstract] [Full Text] [Related]

  • 2. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [Abstract] [Full Text] [Related]

  • 3. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [Abstract] [Full Text] [Related]

  • 4. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 5. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE, Maziak DE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, Gu CS, Kuruvilla MS, Cline KJ, Julian JA, Evans WK, Levine MN.
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [Abstract] [Full Text] [Related]

  • 6. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM, Ak I, Simsek FS, Döner E, Dündar E.
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [Abstract] [Full Text] [Related]

  • 7. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J, Milleron B, Vaylet F, Grahek D, Lebeau B, Mangiapan G, Bonardel G, de Labriolle-Vaylet C, Meignan M, Carette MF, Talbot JN, Housset B.
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [Abstract] [Full Text] [Related]

  • 8. Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC.
    Al-Ibraheem A, Hirmas N, Fanti S, Paez D, Abuhijla F, Al-Rimawi D, Al-Rasheed U, Abdeljalil R, Hawari F, Alrabi K, Mansour A.
    BMC Med Imaging; 2021 Mar 17; 21(1):49. PubMed ID: 33731050
    [Abstract] [Full Text] [Related]

  • 9. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.
    Radiology; 2006 Nov 17; 241(2):501-9. PubMed ID: 16966480
    [Abstract] [Full Text] [Related]

  • 10. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
    Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.
    Ann Thorac Surg; 2005 Jan 17; 79(1):263-8. PubMed ID: 15620955
    [Abstract] [Full Text] [Related]

  • 11. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
    Sánchez Sánchez R, Rodríguez Fernández A, Gómez Río M, Alkurdi Martínez A, Castellón Rubio VE, Ramos Font C, Sánchez-Palencia Ramos A, Delgado Pérez JR, Llamas Elvira JM.
    Rev Esp Med Nucl; 2011 Jan 17; 30(4):211-6. PubMed ID: 21514978
    [Abstract] [Full Text] [Related]

  • 12. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ.
    Chest; 2004 Apr 17; 125(4):1413-23. PubMed ID: 15078754
    [Abstract] [Full Text] [Related]

  • 13. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
    Gómez-Caro A, Garcia S, Reguart N, Arguis P, Sanchez M, Gimferrer JM, Marrades R, Lomeña F.
    Eur J Cardiothorac Surg; 2010 May 17; 37(5):1168-74. PubMed ID: 20116273
    [Abstract] [Full Text] [Related]

  • 14. Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
    Geraldson CT, Stephenson JE, Lagrew JP, Schammel CM, Schammel DP, Greene RA, Bolton WD.
    Am Surg; 2012 Mar 17; 78(3):305-8. PubMed ID: 22524768
    [Abstract] [Full Text] [Related]

  • 15. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 17; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 16. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
    Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P, Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.
    Eur J Cardiothorac Surg; 2001 Sep 17; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
    [Abstract] [Full Text] [Related]

  • 17. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N, Sawabata N, Minami M, Inoue M, Shintani Y, Kadota Y, Okumura M.
    Eur J Cardiothorac Surg; 2012 Jul 17; 42(1):89-92. PubMed ID: 22290887
    [Abstract] [Full Text] [Related]

  • 18. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T, Bundschuh RA, Andratschke N, Mayer B, Specht HM, Papp L, Zsótér N, Essler M.
    Radiat Oncol; 2015 Apr 22; 10():100. PubMed ID: 25900186
    [Abstract] [Full Text] [Related]

  • 19. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP, Yu JM, Guo HB, Fu Z, Han AQ, Yang GR.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 22; 29(6):453-6. PubMed ID: 17974282
    [Abstract] [Full Text] [Related]

  • 20. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep 22; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.